Context: BM-21 is a hydro-ethanolic extract obtained from the leaves of Thalassia testudinum marine plant, which is rich in polyphenols, and it has demonstrated antioxidant, anti-inflammatory, cytoprotective and neuroprotective properties. Aims: To investigate the genotoxicity potential of BM-21. Methods: Salmonella typhimurium Hist. – strains were used in the pointmutation test and Escherichia coli cells were used in SOS response test. DNA primary damage was tested in hepatocytes of mice treated with oral dose of the extract (2000 mg/kg). Bone marrow micronucleus assay was used in mice to detect clastogenic damage while serum from the same animals was used to determine MDA levels in order to find out the influence of BM-21 on lipid peroxidation. Positive and negative controls were included in all experimental series. Results: BM-21 did not increase the frequency of reverse mutations in the Ames test, and it did not induce primary damage in E. coli. Comet assay showed that 2 000 mg/kg of BM-21 induced single strand breaks or alkali-labile sites in the hepatocytes from the treated mice. However, no increase in the micronucleus frequency was observed in mice polychromatic erythrocytes and significantly reduced MDA levels were detected. Conclusions: BM-21 was neither mutagenic nor induces DNA damage to prokaryotic cells. Although, it increased DNA strand breaks in vivo, this one was not translated into clastogenic damage to the whole organism. Results suggested that BM-21 was not mutagenic or genotoxic under our experimental conditions.

Colorectal cancer (CRC) is one of the most lethal cancers worldwide. If detected on time, surgery can expand life expectations of patients up to five more years. However, if metastasis has grown deliberately, the use of chemotherapy can play a crucial role in CRC control. Moreover, the lack of selectivity of current anticancer drugs, plus mutations that occur in cancerous cells, demands the development of new chemotherapeutic agents. Several steroids have shown their potentiality as anticancer agents, while some other compounds, such as Taxol and its derivatives bearing a carbamate functionality, have reached the market. In this article, the synthesis, characterization, and antiproliferative activity of four steroidal carbamates on mouse colon carcinoma CT26WT cells are described. Carbamate synthesis occurred via direct reaction between diosgenin, its B-ring modified derivative, and testosterone with phenyl isocyanate under a Brønsted acid catalysis. All obtained compounds were characterized by ¹H and ¹³C Nuclear Magnetic Resonance (NMR), High Resolution Mass Spectroscopy (HRMS); their melting points are also reported. Results obtained from antiproliferative activity assays indicated that carbamates compounds have inhibitory effects on the growth of this colon cancer cell line. A molecular docking study carried out on Human Prostaglandin E Receptor (EP4) showed a high affinity between carbamates and protein, thus providing a valuable theoretical explanation of the in vitro results.

Poor water-solubility of emerging new chemotherapeutic drugs lead to low absorption and tissue bioavailability. Improved drug delivery has therefore recent